23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also discontinuing its therapeutics business and winding down its clinical trials; it expects these changes to save $35 million annually. “We are taking these difficult but […]
© 2024 TechCrunch. All rights reserved. For personal use only.
Related Posts
Social Media Marketing
ClickMagick Review
AI Email Marketing: What It Is and How To Do It [Research + Tools]
Made in NC: A Guide to 11 Coastal Region North Carolina Wineries
Solve Rural Community Challenges the Idea Friendly Way – stories from IEDC
Leave a Reply